Thursday 30 November 2017

BGRF and SILS scientists analyze viability of shRNA therapy for Huntington's Disease

(Biogerontology Research Foundation) Researchers from the Biogerontology Research Foundation, Department of Molecular Neuroscience at the Swammerdam Institute for Life Sciences at the University of Amsterdam, and the Department of Neurobiology, Care Sciences and Society at the Karolinska Institute announce the publication of a paper in Translational Neurodegeneration, a BioMedCentral journal, titled RNAi mechanisms in Huntington's disease therapy: siRNA versus shRNA.

from EurekAlert! - Social and Behavioral Science http://ift.tt/2j5AOIV

No comments:

Post a Comment